399 related articles for article (PubMed ID: 22037216)
1. TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.
Horiguchi K; Sakamoto K; Koinuma D; Semba K; Inoue A; Inoue S; Fujii H; Yamaguchi A; Miyazawa K; Miyazono K; Saitoh M
Oncogene; 2012 Jun; 31(26):3190-201. PubMed ID: 22037216
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta.
Shirakihara T; Saitoh M; Miyazono K
Mol Biol Cell; 2007 Sep; 18(9):3533-44. PubMed ID: 17615296
[TBL] [Abstract][Full Text] [Related]
3. TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition.
Shirakihara T; Horiguchi K; Miyazawa K; Ehata S; Shibata T; Morita I; Miyazono K; Saitoh M
EMBO J; 2011 Feb; 30(4):783-95. PubMed ID: 21224849
[TBL] [Abstract][Full Text] [Related]
4. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
Fukagawa A; Ishii H; Miyazawa K; Saitoh M
Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
[TBL] [Abstract][Full Text] [Related]
5. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
Gregory PA; Bert AG; Paterson EL; Barry SC; Tsykin A; Farshid G; Vadas MA; Khew-Goodall Y; Goodall GJ
Nat Cell Biol; 2008 May; 10(5):593-601. PubMed ID: 18376396
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
[TBL] [Abstract][Full Text] [Related]
8. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
[TBL] [Abstract][Full Text] [Related]
9. Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1.
Liu L; Chen X; Wang Y; Qu Z; Lu Q; Zhao J; Yan X; Zhang H; Zhou Y
Cancer Gene Ther; 2014 Sep; 21(9):364-72. PubMed ID: 25080992
[TBL] [Abstract][Full Text] [Related]
10. EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-β.
Oktyabri D; Tange S; Terashima M; Ishimura A; Suzuki T
Biochem Biophys Res Commun; 2014 Oct; 453(1):124-30. PubMed ID: 25264103
[TBL] [Abstract][Full Text] [Related]
11. ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor.
Lacher MD; Shiina M; Chang P; Keller D; Tiirikainen MI; Korn WM
Mol Cancer; 2011 Jul; 10():91. PubMed ID: 21791114
[TBL] [Abstract][Full Text] [Related]
12. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
13. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
Du J; Yang S; An D; Hu F; Yuan W; Zhai C; Zhu T
Cell Res; 2009 Apr; 19(4):487-96. PubMed ID: 19308091
[TBL] [Abstract][Full Text] [Related]
14. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.
Eger A; Aigner K; Sonderegger S; Dampier B; Oehler S; Schreiber M; Berx G; Cano A; Beug H; Foisner R
Oncogene; 2005 Mar; 24(14):2375-85. PubMed ID: 15674322
[TBL] [Abstract][Full Text] [Related]
15. The potential role of regulator of G-protein signaling 16 in cell motility mediated by δEF1 family proteins.
Hoshi Y; Endo K; Shirakihara T; Fukagawa A; Miyazawa K; Saitoh M
FEBS Lett; 2016 Jan; 590(2):270-8. PubMed ID: 26823172
[TBL] [Abstract][Full Text] [Related]
16. Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event.
Turini S; Bergandi L; Gazzano E; Prato M; Aldieri E
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609805
[TBL] [Abstract][Full Text] [Related]
17. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.
Gregory PA; Bracken CP; Smith E; Bert AG; Wright JA; Roslan S; Morris M; Wyatt L; Farshid G; Lim YY; Lindeman GJ; Shannon MF; Drew PA; Khew-Goodall Y; Goodall GJ
Mol Biol Cell; 2011 May; 22(10):1686-98. PubMed ID: 21411626
[TBL] [Abstract][Full Text] [Related]
18. Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.
Ishii H; Saitoh M; Sakamoto K; Kondo T; Katoh R; Tanaka S; Motizuki M; Masuyama K; Miyazawa K
J Biol Chem; 2014 Oct; 289(40):27386-99. PubMed ID: 25143390
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
[TBL] [Abstract][Full Text] [Related]
20. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion.
Braeutigam C; Rago L; Rolke A; Waldmeier L; Christofori G; Winter J
Oncogene; 2014 Feb; 33(9):1082-92. PubMed ID: 23435423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]